P094 The environmental burden of melanoma in the UK: a stage-specific carbon footprint analysis
英国におけるメラノーマの環境負荷：病期別カーボンフットプリント分析 (AI 翻訳)
Mythili Ramamurthy Srinivasan, Simon Tso
🤖 gxceed AI 要約
日本語
本研究は、英国のメラノーマ治療における病期別のカーボンフットプリントを初めて推定した。ステージIからIVでCO2排出量が22.5倍に増加することが示され、予防・早期発見の環境的価値を強調している。NHSのネットゼロ目標達成に向けたエビデンスを提供する。
English
This study provides the first UK stage-specific carbon footprint estimates for melanoma care, showing a 22.5-fold increase in emissions from stage I to IV. It demonstrates the substantial environmental burden of late-stage disease and underscores the value of prevention and early detection to reduce both clinical harm and carbon emissions, supporting the NHS net-zero commitment.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本の医療分野でもカーボンフットプリント評価が進む中、本手法はDPCデータ等を用いた診療報酬からのCO2推計に応用可能。厚生労働省のグリーン購入法や医療施設の脱炭素化政策に資する。
In the global GX context
This paper links healthcare costs to carbon emissions, providing a replicable methodology for other countries. It strengthens the case for integrating environmental impact into healthcare decision-making, aligning with global trends toward sustainable healthcare under the Paris Agreement.
👥 読者別の含意
🔬研究者:Method for converting healthcare costs to carbon emissions using input-output analysis, applicable to other diseases and regions.
🏢実務担当者:Healthcare administrators can use stage-specific emission data to prioritize early detection and preventive measures.
🏛政策担当者:Evidence that early cancer detection reduces both clinical costs and carbon footprint, supporting net-zero healthcare policies.
📄 Abstract（原文）
Abstract Healthcare delivery contributes substantially to climate change, accounting for approximately 4–5% of global greenhouse gas emissions. Melanoma is a fatal cancer with rising incidence in the UK, where advanced-stage disease is associated with significant morbidity and mortality and escalating healthcare costs. While the clinical and economic burden of melanoma increases markedly with advancing stage at diagnosis, its environmental impact remains unquantified. The NHS has committed to achieve net zero emissions by 2040. Therefore, estimating the stage-specific carbon footprint of melanoma care provides critical evidence to show that prevention and early detection can reduce the clinical harm, healthcare costs and environmental burden of cancer care, supporting the delivery of sustainable healthcare systems. Our aim was to estimate the stage-specific carbon footprint of melanoma care. Using published 2023 UK data on stage-specific melanoma costs and NHS reference costs, average healthcare costs for each stage of melanoma treatment were calculated. These costs were converted to estimated carbon emissions for each stage by applying a standard UK healthcare carbon intensity factor derived from environmentally extended input–output analysis. In 2023, average treatment costs for stage I, II, III and IV melanoma were £9512, £77 813, £179 274 and £213 801, respectively. Estimated carbon emissions rose sharply with advancing stage, from around 1482 kgCO₂e for stage I to around 33 310 kgCO₂e for stage IV, representing a difference of approximately 31 828 kgCO₂e and a 22.5-fold increase. This study provides the first UK stage-specific estimates of the carbon footprint of melanoma care, demonstrating exponential increases in emissions with advancing stage and the disproportionate environmental burden of late-stage disease. These findings underscore the urgent value of prevention, early detection and timely intervention to maximize clinical benefit while reducing healthcare costs and carbon emissions. We emphasize the importance of incorporating environmental impact alongside economic and clinical outcomes to guide more sustainable cancer care in line with the NHS net zero commitment.
🔗 Provenance — このレコードを発見したソース
- openalex https://doi.org/10.1093/bjd/ljag086.121first seen 2026-06-29 05:39:29 · last seen 2026-06-29 05:39:33
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。